|
|
|
|
January 2010 Briefing - Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for January 2010.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new is available in its catalogue: http://www.reportlinker.com/p0164234/Osteoporosis-Therapeutics---A-Global-Market-Perspective.html Osteoporosis, the most common type of metabolic bone...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Osteoporosis, the most common type of metabolic bone diseases, is an implacable epidemic growing rapidly in regions of North America,...
|
|
|
Osteoporosis Therapeutics A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0164234/Osteoporosis-TherapeuticsA-Global-Market-Perspective.html Osteoporosis, the most common type of...
|
|
|
Osteoporosis Therapeutics - A Global Market Perspective
NEW YORK, Jan.29 /PRNewswire/ -- Reportlinker.com announces that a new is available in its catalogue: http://www.reportlinker.com/p0164234/Osteoporosis-Therapeutics---A-Global-Market-Perspective.html Osteoporosis, the most common type of metabolic bone...
|
|
|
Serum Procalcitonin Levels May Help Guide Antibiotic Use
MONDAY, Jan.25 (HealthDay News) -- In patients with suspected severe bacterial infection, employing antibiotics judiciously based on the serum levels of the calcitonin precursor hormone procalcitonin can reduce antibiotic exposure without increased...
|
|
|
Dr. Reddys to Apply Aegis Intravail Delivery Technology to Marketed Therapeutics
Reddys Laboratoriesnegotiated access to Aegis Therapeutics Intravail drug-delivery technology for use with specific marketed therapeutics that currently represent annual worldwide sales of over $1 billion.Intravail comprises a broad class of chemically...
|
|
|
Treatment of complex regional pain syndrome: a review of the evidence
Tran DQH et al.Only biphosphonates appear to offer clear benefits for patients with CRPS. Improvement has been reported with dimethyl sulfoxide, steroids, epidural clonidine, intrathecal baclofen, spinal cord stimulation, and motor imagery programs, but...
|
|
|
Procalcitonin as a Marker of Severe Bacterial Infection in Children in the Emergency Department
Deis JN et al.Procalcitonin, the prohormone of calcitonin, is a relatively new and innovative marker of bacterial infection that has multiple potential applications in the pediatric emergency department. Procalcitonin as a Marker of Severe Bacterial...
|
|
|
What Is Thyroid Cancer? What Causes Thyroid Cancer?
Thyroid cancer is a type of cancer that occurs in the cells of the thyroid.The thyroid is a butterfly-shaped gland located at the base of the neck. It produces hormones that regulate the heart rate, blood pressure, body temperature and weight. Thyroid...
|
|
|
Early Breast and Prostate Cancer and Clinical Outcomes (Fracture)
Financial Disclosure: Dr.Chlebowski has received speakers fees and honoraria for advisory boards and consulting from AstraZeneca and Novartis; honoraria for advisory boards and consulting for Lilly, Amgen, and Pfizer; and grant support from Amgen, NIH, and...
|
|
|
Early Breast and Prostate Cancer and Clinical Outcomes (Fracture)
Financial Disclosure: Dr.Chlebowski has received speakers fees and honoraria for advisory boards and consulting from AstraZeneca and Novartis; honoraria for advisory boards and consulting for Lilly, Amgen, and Pfizer; and grant support from Amgen, NIH, and...
|
|
|
Emisphere Technologies Reports DMC Recommendation to Proceed with Phase 3 Clinical Trials with Oral Calcitonin
- Emisphere Technologies, Inc.(OTC BB:EMIS) today announced that an independent Data Monitoring Committee (DMC) informed Novartis and its partner Nordic Bioscience about their recommendation to proceed with the Osteoporosis (OP) Phase 3 Study 2303 and the...
|
